Literature DB >> 9672077

Adenovirus-mediated gene transfer of macrophage colony stimulating factor to the arterial wall in vivo.

G Mozes1, T Mohacsi, P Gloviczki, S Menawat, I Kullo, D Spector, J Taylor, T B Crotty, T O'Brien.   

Abstract

Macrophage colony stimulating factor (MCSF) is believed to play a key role in one of the earliest events in atherosclerosis, ie, monocyte to macrophage differentiation in the arterial intima. The aim of this study was to examine the biological effects of vascular wall expression of MCSF. A recombinant adenovirus vector encoding human MCSF (AdMCSF) was generated by standard techniques of homologous recombination in 293 cells. The rabbit carotid artery was transduced with AdMCSF. As negative controls, carotid arteries were transduced with either an adenoviral vector encoding beta-galactosidase, an adenoviral vector encoding apolipoprotein E, or diluent alone. Intima-media thickness ratio was calculated 5 and 21 days after transduction. The cell type present in intimal infiltrates was analyzed by immunohistochemistry. MCSF expression was demonstrated in the vessel wall of AdMCSF-transduced vessels by reverse transcription-polymerase chain reaction and immunofluorescence. In contrast to control vessels, adenovirus-mediated MCSF expression was associated with an intimal cellular infiltrate consisting of smooth muscle cells and small numbers of macrophages. Whereas the intima-media thickness ratio was greater in AdMCSF-transduced vessels at 5 days, this difference was no longer statistically significant at 21 days. These results suggest that MCSF may play a role in recruitment of monocytes and macrophages to the vessel wall and may contribute to smooth muscle cell proliferation and migration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9672077     DOI: 10.1161/01.atv.18.7.1157

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  4 in total

Review 1.  The future of gene therapy for stroke.

Authors:  C A Gunnett; D D Heistad
Journal:  Curr Hypertens Rep       Date:  2001-02       Impact factor: 5.369

2.  Long term treatment with enalapril reduces plasma concentrations of macrophage colony stimulating factor in patients with coronary artery disease.

Authors:  K Sadamatsu; H Shimokawa; H Tashiro; K Yamamoto
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

3.  Beta blockers enhance early diastolic filling in ischaemic heart disease: a radionuclide assessment.

Authors:  E Moralidis; G McCurrach; W Martin; I Hutton
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

4.  Dilated cardiomyopathy and Chlamydia pneumoniae infection.

Authors:  H Song; H Tasaki; A Yashiro; K Yamashita; T Toyokawa; Y Nagai; H Takatsu; H Taniguchi; Y Nakashima
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.